Fix failing adat02 template #186
GitHub Actions / Unit Tests Summary
failed
Oct 10, 2024 in 0s
4 fail, 88 skipped, 248 pass in 1m 2s
Annotations
Check warning on line 0 in tables_ADA_adat01
github-actions / Unit Tests Summary
tables_ADA_adat01.qmd_result_v1_stable (tables_ADA_adat01) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'stable'): ('test-tables-ADA-adat01.R:1:1')
Snapshot of code has changed (variant 'stable'):
old[3:24] vs new[3:24]
Output
Baseline Prevalence and Incidence of Treatment Emergent ADA
- ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination All Drug X B: Placebo All Patients
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=266) (N=134) (N=400)
- ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of ADAs
+ Baseline Prevalence of ADAs
- Baseline evaluable patients 134 132 0 0 266
+ Baseline evaluable patients 134 132 266 0 266
- Patient with a positive sample at baseline 63 (47.0%) 64 (48.5%) 0 0 127 (47.7%)
+ Patient with a positive sample at baseline 63 (47.0%) 64 (48.5%) 127 (47.7%) 0 127 (47.7%)
- Patient with no positive samples at baseline 71 68 0 0 139
+ Patient with no positive samples at baseline 71 68 139 0 139
- Incidence of Treatment Emergent ADAs
+ Incidence of Treatment Emergent ADAs
- Post-baseline evaluable patients 134 132 0 0 266
+ Post-baseline evaluable patients 134 132 266 0 266
- Patient positive for Treatment Emergent ADA 0 0 0 0 0
+ Patient positive for Treatment Emergent ADA 0 0 0 0 0
- Treatment-induced ADA 0 0 0 0 0
+ Treatment-induced ADA 0 0 0 0 0
- Treatment-enhanced ADA 0 0 0 0 0
+ Treatment-enhanced ADA 0 0 0 0 0
- Patient negative for Treatment Emergent ADA 0 0 0 0 0
+ Patient negative for Treatment Emergent ADA 0 0 0 0 0
- Treatment unaffected 0 0 0 0 0
+ Treatment unaffected 0 0 0 0 0
- ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient = a patient with an ADA assay result from a baseline sample(s)
Post-baseline evaluable patient = a patient with an ADA assay result from at least one post-baseline sample Number of patients positive for Treatment Emergent
* Run `testthat::snapshot_accept('stable/tables-ADA-adat01')` to accept the change.
* Run `testthat::snapshot_review('stable/tables-ADA-adat01')` to interactively review the change.
Check warning on line 0 in tables_ADA_adat02
github-actions / Unit Tests Summary
tables_ADA_adat02.qmd_result_v1_stable (tables_ADA_adat02) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'stable'): ('test-tables-ADA-adat02.R:1:1')
Snapshot of code has changed (variant 'stable'):
old[4:21] vs new[4:21]
Summary of Patients with Treatment-Induced ADA, PK Population
Protocol: A: Drug X Antibody
- —————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing>
+ A: Drug X C: Combination
- (N=134) (N=132) (N=0)
+ (N=134) (N=132)
- —————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————
- Post-baseline evaluable patients 134 132 266
+ Post-baseline evaluable patients 134 132
- Treatment-induced ADA patients 0 0 64 (24.1%)
+ Treatment-induced ADA patients 38 (28.4%) 26 (19.7%)
- Treatment-induced ADA patients with
+ Treatment-induced ADA patients with
- Transient ADA 0 0 0
+ Transient ADA 0 0
- Persistent ADA 0 0 0
+ Persistent ADA 0 0
- Median time to onset of ADA (weeks) NA NA 0.1
+ Median time to onset of ADA (weeks) 0.1 0.1
- ADA titer range (min - max) NA NA NA
+ ADA titer range (min - max) NA NA
- —————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————
ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic
Antibodies)
* Run `testthat::snapshot_accept('stable/tables-ADA-adat02')` to accept the change.
* Run `testthat::snapshot_review('stable/tables-ADA-adat02')` to interactively review the change.
Check warning on line 0 in tables_ADA_adat04a
github-actions / Unit Tests Summary
tables_ADA_adat04a.qmd_result_v1_stable (tables_ADA_adat04a) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'stable'): ('test-tables-ADA-adat04a.R:1:1')
Snapshot of code has changed (variant 'stable'):
old[4:27] vs new[4:27]
Baseline Prevalence and Incidence of Treatment Emergent NAbs
Protocol: A: Drug X Antibody
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination All Drug X B: Placebo All Patients
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=266) (N=134) (N=400)
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of NAbs
+ Baseline Prevalence of NAbs
- Baseline evaluable patients for ADA 134 132 0 0 266
+ Baseline evaluable patients for ADA 134 132 266 0 266
- Patients with a positive ADA sample at baseline 63 64 0 0 127
+ Patients with a positive ADA sample at baseline 63 64 127 0 127
- Patients with a positive NAb sample at baseline 0 0 0 0 0
+ Patients with a positive NAb sample at baseline 0 0 0 0 0
- Patient with no positive NAb samples at baseline 0 0 0 0 0
+ Patient with no positive NAb samples at baseline 0 0 0 0 0
- Incidence of Treatment Emergent NAbs
+ Incidence of Treatment Emergent NAbs
- Post-baseline evaluable patients for ADA 134 132 0 0 266
+ Post-baseline evaluable patients for ADA 134 132 266 0 266
- Patients positive for ADA 66 59 0 0 125
+ Patients positive for ADA 66 59 125 0 125
- Patients positive for Treatment Emergent NAb 0 0 0 0 0
+ Patients positive for Treatment Emergent NAb 0 0 0 0 0
- Treatment-induced NAb 0 0 0 0 0
+ Treatment-induced NAb 0 0 0 0 0
- Treatment-enhanced NAb 0 0 0 0 0
+ Treatment-enhanced NAb 0 0 0 0 0
- Patients negative for NAb 0 0 0 0 0
+ Patients negative for NAb 0 0 0 0 0
- Treatment unaffected 0 0 0 0 0
+ Treatment unaffected 0 0 0 0 0
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
NAb = Neutralizing Antibodies ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient for ADA = a patient with an ADA assay result from a baseline sample(s)
Baseline evaluable patient for NAb = a patient with a NAb assay result from a baseline sample(s)
* Run `testthat::snapshot_accept('stable/tables-ADA-adat04a')` to accept the change.
* Run `testthat::snapshot_review('stable/tables-ADA-adat04a')` to interactively review the change.
Check warning on line 0 in tables_ADA_adat04b
github-actions / Unit Tests Summary
tables_ADA_adat04b.qmd_result_v1_stable (tables_ADA_adat04b) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'stable'): ('test-tables-ADA-adat04b.R:1:1')
Snapshot of code has changed (variant 'stable'):
old[4:24] vs new[4:24]
Baseline Prevalence and Incidence of Neutralizing Antibodies (NAbs)
Protocol: A: Drug X Antibody
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination All Drug X B: Placebo All Patients
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=266) (N=134) (N=400)
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of NAbs
+ Baseline Prevalence of NAbs
- Baseline evaluable patients for ADA 134 132 0 0 266
+ Baseline evaluable patients for ADA 134 132 266 0 266
- Patients with a positive ADA sample at baseline 63 64 0 0 127
+ Patients with a positive ADA sample at baseline 63 64 127 0 127
- Patients with a positive NAb sample at baseline 0 0 0 0 0
+ Patients with a positive NAb sample at baseline 0 0 0 0 0
- Patients with no positive NAb sample at baseline 0 0 0 0 0
+ Patients with no positive NAb sample at baseline 0 0 0 0 0
- Incidence of NAbs
+ Incidence of NAbs
- Post-baseline evaluable patients for ADA 134 132 0 0 266
+ Post-baseline evaluable patients for ADA 134 132 266 0 266
- Patients positive for ADA 66 59 0 0 125
+ Patients positive for ADA 66 59 125 0 125
- Patients positive for NAb 0 0 0 0 0
+ Patients positive for NAb 0 0 0 0 0
- Patients negative for NAb 134 132 0 0 266
+ Patients negative for NAb 134 132 266 0 266
- —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
NAb = Neutralizing Antibodies ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient for ADA = a patient with an ADA assay result from a baseline sample(s) Baseline evaluable patient for NAb = a patient with a NAb assay result from a baseline sample(s) Post-baseline evaluable patient for ADA = a patient with an ADA assay result from at least one post-baseline sample Post-baseline evaluable patient for NAb = a patient with a NAb assay result from at least one post-baseline sample Number of patients positive for ADA = the number of post-baseline evaluable patients for ADA determined to have Treatment Emergent ADA during the study period.
Number of patients positive for NAb = the number (and percentage) of post-baseline evaluable patients for ADA determined to have at least one positive post-baseline NAb result during the study period. Number of patients negative for NAb = number of post-baseline evaluable patients with all negative post-baseline NAb results.
* Run `testthat::snapshot_accept('stable/tables-ADA-adat04b')` to accept the change.
* Run `testthat::snapshot_review('stable/tables-ADA-adat04b')` to interactively review the change.
Loading